JP2008540685A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540685A5 JP2008540685A5 JP2008512588A JP2008512588A JP2008540685A5 JP 2008540685 A5 JP2008540685 A5 JP 2008540685A5 JP 2008512588 A JP2008512588 A JP 2008512588A JP 2008512588 A JP2008512588 A JP 2008512588A JP 2008540685 A5 JP2008540685 A5 JP 2008540685A5
- Authority
- JP
- Japan
- Prior art keywords
- oxolan
- hydroxymethyl
- purin
- dihydroxy
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *[C@@]([C@@]([C@]1O)O)O[C@]1[n]1c2nc(*3N=C(*)C(*)=C3*)nc(N*)c2nc1 Chemical compound *[C@@]([C@@]([C@]1O)O)O[C@]1[n]1c2nc(*3N=C(*)C(*)=C3*)nc(N*)c2nc1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68350505P | 2005-05-19 | 2005-05-19 | |
| PCT/US2006/019694 WO2006125211A1 (en) | 2005-05-19 | 2006-05-19 | A1 adenosine receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008540685A JP2008540685A (ja) | 2008-11-20 |
| JP2008540685A5 true JP2008540685A5 (enExample) | 2009-07-02 |
Family
ID=36950224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008512588A Pending JP2008540685A (ja) | 2005-05-19 | 2006-05-19 | Ａ１アデノシンレセプターアゴニスト |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7514417B2 (enExample) |
| EP (1) | EP1881991A1 (enExample) |
| JP (1) | JP2008540685A (enExample) |
| CA (1) | CA2609117A1 (enExample) |
| WO (1) | WO2006125211A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2657973A1 (en) * | 2006-06-27 | 2008-01-03 | Biovitrum Ab (Publ) | Therapeutic compounds |
| NZ579248A (en) * | 2007-03-28 | 2011-08-26 | Neurosearch As | Purinyl derivatives and their use as potassium channel modulators |
| EP2142547A1 (en) | 2007-03-28 | 2010-01-13 | NeuroSearch A/S | Purinyl derivatives and their use as potassium channel modulators |
| EP2268641B1 (en) * | 2008-03-26 | 2014-09-03 | Advinus Therapeutics Pvt. Ltd. | Heterocyclic compounds as adenosine receptor antagonist |
| WO2010034707A1 (en) | 2008-09-26 | 2010-04-01 | Neurosearch A/S | Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| JP6223443B2 (ja) | 2012-06-26 | 2017-11-01 | サニオナ・エイピイエス | フェニルトリアゾール誘導体及びｇａｂａａ受容体複合体を調節するための該フェニルトリアゾール誘導体の使用 |
| JO3215B1 (ar) | 2012-08-09 | 2018-03-08 | Phenex Pharmaceuticals Ag | حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy |
| WO2014105958A2 (en) | 2012-12-26 | 2014-07-03 | Medivation Technologies, Inc. | Fused pyrimidine compounds and use thereof |
| AU2021413448A1 (en) * | 2020-12-29 | 2023-07-20 | Zhejiang Vimgreen Pharmaceuticals, Ltd | Adenosine a3 receptor agonists, preparation methods and uses thereof |
| US20240247001A1 (en) | 2022-12-16 | 2024-07-25 | Astrazeneca Ab | 2,6,9-trisubstituted purines |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030078232A1 (en) * | 2001-08-08 | 2003-04-24 | Elfatih Elzein | Adenosine receptor A3 agonists |
| US7262176B2 (en) * | 2001-08-08 | 2007-08-28 | Cv Therapeutics, Inc. | Adenosine A3 receptor agonists |
-
2006
- 2006-05-19 EP EP06770812A patent/EP1881991A1/en not_active Withdrawn
- 2006-05-19 CA CA002609117A patent/CA2609117A1/en not_active Abandoned
- 2006-05-19 WO PCT/US2006/019694 patent/WO2006125211A1/en not_active Ceased
- 2006-05-19 US US11/437,242 patent/US7514417B2/en active Active
- 2006-05-19 JP JP2008512588A patent/JP2008540685A/ja active Pending
-
2009
- 2009-02-23 US US12/391,174 patent/US20090156544A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008540685A5 (enExample) | ||
| JP2008540683A5 (enExample) | ||
| US11780826B2 (en) | Bisamide sarcomere activating compounds and uses thereof | |
| AU2014355887B2 (en) | Urea derivative or pharmacologically acceptable salt thereof | |
| US8933105B2 (en) | Pyrrole compounds | |
| EP1803709B1 (en) | Proton pump inhibitors | |
| JP5856211B2 (ja) | Ｍｅｋインヒビターおよびその使用方法 | |
| CN107428719B (zh) | 用于治疗扩张性心肌病(dcm)的4-甲基磺酰基取代的哌啶脲化合物 | |
| EP2678332B1 (en) | Diaminopyrimidine derivatives and processes for the preparation thereof | |
| CA2476683A1 (en) | Partial and full agonists of a1 adenosine receptors | |
| JP2005527502A5 (enExample) | ||
| JP6964576B2 (ja) | 置換４−アザインドール及びｇｌｕｎ２ｂ受容体調節因子としてのそれらの使用 | |
| JP2005501842A5 (enExample) | ||
| RU2004106635A (ru) | Агонисты а3 рецепторов аденозина | |
| US20230158024A1 (en) | Cd38 inhibitors | |
| HRP20171991T1 (hr) | Derivati pirolidin karbonske kiseline kao agonisti g-protein spojenog receptora (gpr43), farmaceutski pripravak i postupci za primjenu u liječenju poremećaja metabolizma | |
| CN1358189A (zh) | C－吡唑a2a受体激动剂 | |
| JP2005530736A5 (enExample) | ||
| RU2009127781A (ru) | Производные аденозина в качестве частичных и полных агонистов а1 аденозиновых рецепторов | |
| US20180208552A1 (en) | Urea derivative or pharmacologically acceptable salt thereof | |
| JP2008509955A5 (enExample) | ||
| DK2059503T3 (en) | Aminopyrazole derivatives, processes for their preparation, and compositions containing these derivatives for the prevention or treatment of ischemic diseases | |
| JP2020512401A (ja) | Ｇｐｒ６のモジュレーターとしてのピペリジニルおよびピペラジニル置換された複素芳香族カルボキサミド | |
| KR20090096742A (ko) | 피리딘 화합물 및 ｐ２ｙ１２ 길항제로서의 그 용도 | |
| TWI427076B (zh) | 化合物及用於抗病毒治療之方法 |